Literature DB >> 25491196

Relationship between serum uric Acid and bone mineral density in the general population and in rats with experimental hyperuricemia.

Dihua Zhang1,2, I Alexandru Bobulescu1,2, Naim M Maalouf1,2, Beverley Adams-Huet1,2,3, John Poindexter1,2, Sun Park2, Fuxin Wei4, Christopher Chen2,4, Orson W Moe1,2,5, Khashayar Sakhaee1,2.   

Abstract

UNLABELLED: Higher serum uric acid concentrations have been associated with higher bone mineral density (BMD) in observational studies of older men and perimenopausal or postmenopausal women, prompting speculation of a potential protective effect of uric acid on bone. Whether this relationship is present in the general population has not been examined and there is no data to support causality. We conducted a cross-sectional analysis of a probability sample of the U.S. POPULATION: Demographic data, dietary intake, lifestyle risk factors and physical activity assessment data, serum biochemistry including serum uric acid, and BMD were obtained from 6759 National Health and Nutrition Examination Survey (NHANES; 2005-2010) participants over 30 years of age. In unadjusted analyses, higher serum uric acid levels were associated with higher BMD at the femoral neck, total hip, and lumbar spine in men, premenopausal women, and postmenopausal women not treated with estrogen. However, these associations were no longer statistically significant after adjustment for potential confounders, including age, body mass index (BMI), black race, alcohol consumption, estimated glomerular filtration rate (eGFR), serum alkaline phosphatase, and C-reactive protein (CRP). This is in contradistinction to some prevailing conclusions in the literature. To further examine the causal effect of higher serum uric acid on skeletal health, including biomechanical properties that are not measurable in humans, we used an established rat model of inducible mild hyperuricemia. There were no differences in BMD, bone volume density, and bone biomechanical properties between hyperuricemic rats and normouricemic control animals. Taken together, our data do not support the hypothesis that higher serum uric acid has protective effects on bone health.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ANALYSIS/QUANTITATION OF BONE; BIOCHEMICAL MARKERS OF BONE TURNOVER; BONE MODELING AND REMODELING; DISEASES AND DISORDERS OF/RELATED TO BONE; DXA; HORMONE REPLACEMENT/RECEPTOR MODULATORS; OSTEOPOROSIS; THERAPEUTICS

Mesh:

Substances:

Year:  2015        PMID: 25491196      PMCID: PMC4439277          DOI: 10.1002/jbmr.2430

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

1.  Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study.

Authors:  Dario Maggio; Mauro Barabani; Marco Pierandrei; M Cristina Polidori; Marco Catani; Patrizia Mecocci; Umberto Senin; Roberto Pacifici; Antonio Cherubini
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

2.  Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).

Authors:  I Holme; A H Aastveit; N Hammar; I Jungner; G Walldius
Journal:  J Intern Med       Date:  2009-05-26       Impact factor: 8.989

3.  Simplified calculation of body-surface area.

Authors:  R D Mosteller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

4.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

5.  Osteoporosis and its complications.

Authors:  Matthew A Varacallo; Ed J Fox
Journal:  Med Clin North Am       Date:  2014-05-09       Impact factor: 5.456

Review 6.  Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure.

Authors:  Corinna Bergamini; Mariantonietta Cicoira; Andrea Rossi; Corrado Vassanelli
Journal:  Eur J Heart Fail       Date:  2009-04-04       Impact factor: 15.534

7.  Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) study.

Authors:  Nancy E Lane; Neeta Parimi; Li-Yung Lui; Barton L Wise; Wei Yao; Yu-An Evan Lay; Peggy M Cawthon; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2014-07       Impact factor: 6.741

8.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 10.  The conundrum of hyperuricemia, metabolic syndrome, and renal disease.

Authors:  Takahiko Nakagawa; Pietro Cirillo; Waichi Sato; Michael Gersch; Yuri Sautin; Carlos Roncal; Wei Mu; L Gabriela Sánchez-Lozada; Richard J Johnson
Journal:  Intern Emerg Med       Date:  2008-03-05       Impact factor: 3.397

View more
  22 in total

1.  Association of gout with osteoporotic fractures.

Authors:  Yanmao Wang; Runhua Zhou; Wanrun Zhong; Chengfang Hu; Shengdi Lu; Yimin Chai
Journal:  Int Orthop       Date:  2018-06-28       Impact factor: 3.075

2.  Serum uric acid is associated with quantitative ultrasound parameters in men: data from the Camargo cohort.

Authors:  J L Hernández; D Nan; J Martínez; E Pariente; I Sierra; J González-Macías; J M Olmos
Journal:  Osteoporos Int       Date:  2015-03-03       Impact factor: 4.507

3.  Gout and Risk of Fracture in Women: A Prospective Cohort Study.

Authors:  Julie M Paik; Seoyoung C Kim; Diane Feskanich; Hyon K Choi; Daniel H Solomon; Gary C Curhan
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

4.  Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population.

Authors:  Dan-Dan Yan; Jie Wang; Xu-Hong Hou; Yu-Qian Bao; Zhen-Lin Zhang; Cheng Hu; Wei-Ping Jia
Journal:  Acta Pharmacol Sin       Date:  2017-12-14       Impact factor: 6.150

Review 5.  The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis.

Authors:  P Yin; H Lv; Y Li; Y Meng; L Zhang; P Tang
Journal:  Osteoporos Int       Date:  2017-05-09       Impact factor: 4.507

Review 6.  The role of uric acid in mineral bone disorders in chronic kidney disease.

Authors:  Baris Afsar; Alan A Sag; Cinar Oztosun; Masanari Kuwabara; Mario Cozzolino; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

7.  Association between serum uric acid and bone health in adolescents.

Authors:  F Karimi; M H Dabbaghmanesh; G R Omrani
Journal:  Osteoporos Int       Date:  2019-07-04       Impact factor: 4.507

8.  Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.

Authors:  M Pirro; M R Mannarino; V Bianconi; S De Vuono; A Sahebkar; F Bagaglia; L Franceschini; A M Scarponi; E Mannarino; T Merriman
Journal:  Osteoporos Int       Date:  2016-10-10       Impact factor: 4.507

9.  Higher serum uric acid is associated with higher lumbar spine bone mineral density in male health-screening examinees: a cross-sectional study.

Authors:  Jiwon Hwang; Jung Hye Hwang; Seungho Ryu; Joong Kyong Ahn
Journal:  J Bone Miner Metab       Date:  2018-01-25       Impact factor: 2.626

10.  No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity--a Mendelian randomization study.

Authors:  A Xiong; Q Yao; J He; W Fu; J Yu; Z Zhang
Journal:  Osteoporos Int       Date:  2015-11-20       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.